«

»

Resistant Hypertension: A review of Diagnosis and Management

by jmiller on June 11, 2014

This JAMA “Grand Rounds” CME article concludes that an increasing body of evidence has suggested benefits of mineralocorticoid receptor antagonists, such as eplerenone and spironolactone, in improving blood pressure control in patients with resistant hypertension, regardless of cirulating aldosterone levels.  Thus, this class of drugs should be considered for patients whose blood pressure remains elevated after treatment with a 3-drug regimen to patients whose blood presure remains elevated after treatment with a 3-drug regimen to maximal or near maximal doses.  Click here to read full text.

Leave a Reply

Your email address will not be published.